Henry Rodriguez: Unraveling the mysteries of small cell lung cancer

Henry Rodriguez, Founding Director of the Office of Cancer Clinical Proteomics Research at the NCI, shared on LinkedIn:

“Exciting news in SCLC! A collaborative study by the National Cancer Institute (NCI), ICPC (International Cancer Proteogenome Consortium) China Team, and CPTAC (Clinical Proteomic Tumor Analysis Consortium) has published a comprehensive study, unraveling the mysteries of small cell lung cancer.

Their proteogenomic insights could pave the way for subtype-specific therapies. Kudos!”

View additional information.
Source: Henry Rodriguez/LinkedIn